Copyright
©The Author(s) 2017.
World J Gastroenterol. Aug 14, 2017; 23(30): 5499-5507
Published online Aug 14, 2017. doi: 10.3748/wjg.v23.i30.5499
Published online Aug 14, 2017. doi: 10.3748/wjg.v23.i30.5499
Figure 5 Liver gene expression of target genes for LAN treatment (SSTR2, SSTR5) and for PI3K/Akt/mTOR pathway (mTOR, Rptor).
A: expression of the Somatostatin receptors SSTR2 and SSTR5; B: expression of mTOR and of Rptor. The mean for delta Ct value (with SE) is given vs that for the reference (housekeeping gene) β2M. To be noted, a higher value means a lower expression. CON: Control; LAN: Lanreotide; EVR: Everolimus.
- Citation: Temmerman F, Chen F, Libbrecht L, Vander Elst I, Windmolders P, Feng Y, Ni Y, De Smedt H, Nevens F, van Pelt J. Everolimus halts hepatic cystogenesis in a rodent model of polycystic-liver-disease. World J Gastroenterol 2017; 23(30): 5499-5507
- URL: https://www.wjgnet.com/1007-9327/full/v23/i30/5499.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i30.5499